Drug · DIN 02472104
LONSURF
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 22, 2018; first marketed March 22, 2018.
- Drug Identification Number (DIN)
- 02472104
- Company (DIN owner)
- Taiho Pharma Canada, Inc.Oakville, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Trifluridine, combinations L01BC59
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRIFLURIDINE | 15 MG | |
| TIPIRACIL (TIPIRACIL HYDROCHLORIDE) | 6.14 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 25, 2018: NOC 20405New Drug Submission (NDS)
Other DINs named LONSURF
- DIN 02472112 · Marketed